The three mechanisms of carrier-mediated transport are facilitated diffusion, primary active transport, and secondary active transport. All three rely on carrier proteins that bind to specific molecules and change shape to shuttle them across the cell membrane. This distinguishes them from channel proteins, which form open pores that molecules flow through freely, and from simple diffusion, where molecules pass directly through the membrane’s fatty layer without any protein assistance.
What unites these three mechanisms is the carrier protein itself. Unlike channels, which allow over a million ions per second to rush through, carrier proteins work more slowly because each transport event requires the protein to physically shift between two shapes: one that faces the outside of the cell and one that faces the inside. This shape-shifting process also means carrier-mediated transport can become saturated. Once every available carrier protein is occupied, adding more of the transported molecule won’t speed things up. The transport rate hits a ceiling.
Facilitated Diffusion
Facilitated diffusion moves molecules down their concentration gradient, from where they’re more concentrated to where they’re less concentrated. No energy input is required. The carrier protein simply provides a path for molecules that can’t cross the membrane on their own because they’re too large, too charged, or too water-soluble to slip through the fatty interior of the membrane.
The glucose transporter family (known as GLUTs) is the classic example. These carrier proteins sit in the cell membrane and alternate between two shapes. In one shape, the binding site faces the outside of the cell and picks up a glucose molecule. The protein then shifts so the binding site faces inward, releasing glucose into the cell. Because glucose is constantly being broken down inside the cell, its concentration stays lower indoors than out, and the gradient keeps driving glucose inward without any energy cost.
There are at least 14 known GLUT transporters, each tailored to specific tissues and sugars. GLUT4, found in muscle and fat tissue, is especially interesting because insulin controls how many copies sit in the membrane at any given time. When insulin signals arrive, GLUT4 transporters move from storage compartments inside the cell to the surface, increasing glucose uptake 10- to 20-fold. GLUT5, by contrast, primarily transports fructose and is concentrated in the small intestine and kidneys.
A key feature of facilitated diffusion carriers is specificity. The glucose transporter in red blood cells, for example, has binding sites that recognize glucose’s particular shape. Molecules with similar structures can compete for that binding site, effectively blocking glucose transport. This competitive behavior is one of the hallmarks that distinguishes carrier-mediated transport from simple diffusion through the membrane.
Primary Active Transport
Primary active transport moves molecules against their concentration gradient, pushing them from where they’re scarce to where they’re already abundant. This requires energy, and the carrier protein gets it by directly breaking down ATP, the cell’s energy currency.
The sodium-potassium pump is the best-known example. Every cycle, it pushes 3 sodium ions out of the cell and pulls 2 potassium ions in, consuming one ATP molecule in the process. Both ions are moved against their natural gradients: sodium is already more concentrated outside the cell, and potassium is already more concentrated inside. The pump forces them further apart anyway, maintaining the electrical and chemical imbalance that cells depend on for signaling, muscle contraction, and dozens of other functions.
This pump is expensive to run. In brain cells called astrocytes, the sodium-potassium pump alone accounts for about 20% of all ATP consumption even under resting conditions. Across the body, it’s estimated to use an even larger share in tissues like the kidneys and nervous system, where ion gradients are critical.
The “primary” label matters because these pumps create the ion gradients that power the third type of carrier-mediated transport.
Secondary Active Transport
Secondary active transport also moves molecules against their concentration gradient, but it doesn’t burn ATP directly. Instead, it piggybacks on the ion gradients that primary active transport has already built. A carrier protein harnesses the energy stored in a sodium or hydrogen ion gradient, letting those ions flow downhill while dragging another molecule uphill at the same time.
This mechanism comes in two varieties based on direction.
Symport (Cotransport)
In symport, the driving ion and the transported molecule move in the same direction. The sodium-glucose cotransporter SGLT1, found in the intestinal lining, is a well-studied example. It binds 2 sodium ions and 1 glucose molecule simultaneously, then uses sodium’s natural tendency to rush into the cell (down its gradient, maintained by the sodium-potassium pump) to pull glucose in against its own gradient. This is how your intestines absorb glucose from food even when glucose concentration inside the intestinal cells is already high.
Antiport (Exchange)
In antiport, the driving ion and the transported molecule move in opposite directions. The sodium-hydrogen exchanger is a common example: sodium flows into the cell (down its gradient) while hydrogen ions are pushed out. This helps regulate the cell’s internal pH. Calcium exchangers work on a similar principle, using the inward flow of sodium to push calcium out of the cell and keep intracellular calcium levels extremely low.
A single carrier protein can even combine both modes. The serotonin transporter, which recycles the mood-regulating chemical serotonin from the space between nerve cells, moves serotonin inward along with sodium and chloride (symport) while simultaneously moving potassium outward (antiport).
Shared Features of All Three Mechanisms
Despite their differences in energy source and direction, all three mechanisms share several properties that set carrier-mediated transport apart from channels and simple diffusion.
- Specificity: Each carrier protein recognizes and binds only certain molecules, much like a lock and key. The glucose transporter won’t carry amino acids, and the sodium-potassium pump won’t move calcium.
- Saturation: Because the carrier must change shape with each transport cycle, there’s a maximum transport rate. Once all carriers are busy, increasing the molecule’s concentration won’t increase the rate any further.
- Competition: Molecules with similar shapes can compete for the same binding site. In red blood cells, several structurally different compounds can bind the glucose transporter and reduce its affinity for glucose itself.
What Happens When Carriers Malfunction
Because carrier proteins are so specific, a genetic defect in a single transporter can cause disease. Cystinuria is a clear example. Mutations in the genes encoding a carrier protein responsible for reabsorbing the amino acid cystine in the kidneys cause cystine to accumulate in the urine, where it forms kidney stones. The transporter normally also handles three other amino acids (ornithine, lysine, and arginine), and all four build up when the carrier doesn’t work.
Carrier proteins are also drug targets. SGLT2 inhibitors, originally developed for type 2 diabetes, block the sodium-glucose cotransporter in the kidneys so that excess glucose is excreted in the urine rather than reabsorbed. These drugs are now being tested in clinical trials for conditions beyond diabetes, including cystinuria, where blocking SGLT2 may help reduce stone formation by altering urine chemistry.